EFFECTS OF THE BENZAZEPINE SCH-23390 ON PROLACTIN-RELEASE FROM ISOLATED PITUITARY

被引：3

作者：

NAVARRA, P

DELCARMINE, R

RAGAZZONI, E

VACCA, M

PREZIOSI, P

机构：

[1] UNIV CATTOLICA SACRO CUORE, DEPT PHARMACOL, LARGO F VITO 1, I-00168 ROME, ITALY

[2] UNIV SASSARI, I-07100 SASSARI, ITALY

来源：

PHARMACOLOGY & TOXICOLOGY | 1988年 / 63卷 / 02期

关键词：

D O I：

10.1111/j.1600-0773.1988.tb00925.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：135 / 136

页数：2

共 10 条

[1] INTERACTION OF SCH-23390, A D-1-SELECTIVE ANTAGONIST, WITH THE ANTERIOR-PITUITARY D-2 RECEPTORS AND PROLACTIN SECRETION IN THE RAT [J].

APUD, JA ;

MASOTTO, C ;

ONGINI, E ;

RACAGNI, G .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 112 (02) :187-193

[2] CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].

BILLARD, W ;

RUPERTO, V ;

CROSBY, G ;

IORIO, LC ;

BARNETT, A .

LIFE SCIENCES, 1984, 35 (18) :1885-1893

[3] DOPAMINE LEVELS IN HYPOPHYSEAL STALK BLOOD IN RAT ARE SUFFICIENT TO INHIBIT PROLACTIN SECRETION INVIVO [J].

GIBBS, DM ;

NEILL, JD .

ENDOCRINOLOGY, 1978, 102 (06) :1895-1900

[4] RELEASE OF NEWLY SYNTHESIZED DOPAMINE INTO THE HYPOPHYSEAL PORTAL VASCULATURE OF THE RAT [J].

GUDELSKY, GA ;

PORTER, JC .

ENDOCRINOLOGY, 1979, 104 (03) :583-587

[5]

IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462

[6] STRUCTURAL DETERMINANTS OF SELECTIVE AFFINITY FOR BRAIN D-1 DOPAMINE-RECEPTORS WITHIN A SERIES OF 1-PHENYL-1H-3-BENZAZEPINE ANALOGS OF SK-AND-F-38393 AND SCH-23390 [J].

OBOYLE, KM ;

WADDINGTON, JL .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 115 (2-3) :291-295

[7] SCH 23390 BLOCKS D-1 AND D-2 DOPAMINE-RECEPTORS IN RAT NEOSTRIATUM INVITRO [J].

PLANTJE, JF ;

DAUS, FJ ;

HANSEN, HA ;

STOOF, JC .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (02) :180-182

[8] ABSENCE OF [H-3] SCH-23390 SPECIFIC BINDING-SITES IN ANTERIOR-PITUITARY - DISSOCIATION FROM EFFECTS ON PROLACTIN SECRETION [J].

ROVESCALLI, AC ;

BRUNELLO, N ;

MONOPOLI, A ;

ONGINI, E ;

RACAGNI, G .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 135 (02) :129-136

[9]

TILDERS FJH, 1985, FED PROC, V44, P155

[10]

VANDERSCHUEREN B, 1982, ENDOCRINOLOGY, V110, P513

← 1 →